Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Rua Bioscience Limited Regulatory Filings 2024

Oct 21, 2024

66262_rns_2024-10-22_43873f5e-eb9b-4928-a193-123bfbc2b7fc.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

MARKET UPDATE

==> picture [132 x 77] intentionally omitted <==

FOR PUBLIC RELEASE NZX Limited Wellington

22[nd] October 2024

Update: Unconditional sales contract of Rua manufacturing facility

At the time of the release of the Rua Bioscience FY24 Annual Report on 1 October, 2024 the Directors had accommodated a payment date deferral for the deposit to allow the purchaser (Awa Ora Genesis Kaitiaki Harakeke Trust of Te Araroa) to more explicitly secure land ownership rights once the lease has been transferred.

At the time of this announcement, land ownership rights have now been explicitly secured, however Rua has not yet received the 10% deposit that is due under the contract.

Rua is in regular communication with the purchaser and they have confirmed that full settlement is expected as contractually agreed on 30 October, 2024.

ENDS

The person who authorised this announcement:

Paul Naske Chief Executive Officer [email protected] +64 21 445154

PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com